Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Heung Tae Kim, M.D., Ph.D
Woman and Man Max 99 years
Heung Tae Kim, M.D., Ph.D
Update Il y a 4 ans
Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients
The purpose of this study is to evaluate the efficacy and safety of Belotecan administered 5 days every 3 weeks in comparison to Topotecan in Patients with relapsed small cell lung cancer.
Country
None
organs
None
Specialty
None
Opened trial
More information